These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24723045)

  • 1. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients.
    Jia R; Xu S; Huang X; Song X; Pan H; Zhang L; He F; Lin M; Ge S; Fan X
    JAMA Ophthalmol; 2014 Aug; 132(8):942-8. PubMed ID: 24723045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of orbital vascular malformations with intralesional injection of pingyangmycin.
    Yue H; Qian J; Elner VM; Guo J; Yuan YF; Zhang R; Ge Q
    Br J Ophthalmol; 2013 Jun; 97(6):739-45. PubMed ID: 23603483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW; Yang XJ; Wang YA; He Y; Ye WM; Zhang ZY
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intralesional injection of Pingyangmycin for treatment of venous-venular malformation in the maxillofacial regions of children: report of 306 cases].
    Shou BQ; Shou WD; Yang Z; Meng ZY; Zhang SL; Cao G; Dong Z
    Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):136-9. PubMed ID: 16685351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations.
    Chen Y; Li Y; Zhu Q; Zeng Q; Zhao J; He X; Mei Q
    AJR Am J Roentgenol; 2008 Apr; 190(4):966-71. PubMed ID: 18356443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.
    Bai N; Chen YZ; Fu YJ; Wu P; Zhang WN
    J Clin Pharm Ther; 2014 Oct; 39(5):521-6. PubMed ID: 24924412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of lauromacrogol combined with pingyangmycin in the treatment of venous malformation: clinical analysis of 120 consecutive cases].
    Liu L; Liu DX; Zhao JH; Cai Y; Zhong HY
    Shanghai Kou Qiang Yi Xue; 2016 Oct; 25(5):588-592. PubMed ID: 28116433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China.
    Hou R; Guo J; Hu K; Yang Y; Wang L; Kong L; Liu G; Lei D
    J Vasc Surg; 2010 Apr; 51(4):940-5. PubMed ID: 20347690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrochemical therapy combined with pingyangmycin injection in the management of high-return flow venous malformation].
    Wei JJ; Li QJ; Xue L; Jin ZL; Yuan WL; Wang XK
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Mar; 47(3):160-3. PubMed ID: 22800669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region.
    Zhi K; Wen Y; Li L; Ren W
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):593-7. PubMed ID: 18294701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional injection of pingyangmycin is a safe and effective treatment for microcystic lymphatic malformations in the tongue.
    Mai HM; Zheng JW; Zhou Q; Yang XJ; Wang YA; Fan XD
    Phlebology; 2013 Apr; 28(3):147-52. PubMed ID: 22378834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT; Adams S; Adams K; Hudson DA
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Xanthelasma Palpebrarum With Intralesional Pingyangmycin.
    Wang H; Shi Y; Guan H; Liu C; Zhang W; Zhang Y; Liu A; Qian Y; Zhao Y; Jiang H
    Dermatol Surg; 2016 Mar; 42(3):368-76. PubMed ID: 26890801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
    Hassan Y; Osman AK; Altyeb A
    Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose Bleomycin Injections for Orbital Lymphatic and Lymphatic-Venous Malformations: A Multicentric Case Series Study.
    Prat D; Gomel N; Zloto O; Anne M; BenSaid A; Bhattacharjee K; Yassur I; Sagiv O; Ben Simon GJ
    Ophthalmic Plast Reconstr Surg; 2021 Jul-Aug 01; 37(4):361-365. PubMed ID: 33156144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the clinical therapeutic effects between local injection of pingyangmycin and sodium morrhuate on oral and maxillofacial venous malformation].
    He W; Gu AL; Shang JL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):308-9. PubMed ID: 17686287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
    Liu Y; Liu D; Wang Y; Zhang W; Zhao F
    J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of deep-seated facial microcystic lymphatic malformations with intralesional injection of pingyangmycin.
    Wu HW; Wang X; Zheng JW; Zhao HG; Ge J; Zhang L; Wang YA; Su LX; Fan XD
    Medicine (Baltimore); 2016 Sep; 95(37):e4790. PubMed ID: 27631231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.
    Hou J; Wang M; Tang H; Wang Y; Huang H
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1246-51. PubMed ID: 21893396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional diode laser pretreatment facilitates surgery for orbital venous malformations: initial experience with 23 consecutive patients.
    Xie M; Li T; Luo Y; Li Y; Wang Y; Fan X; Heindl LM; Jia R
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):303-309. PubMed ID: 34379188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.